In Depth 18 Jul 2022
Deep phenotyping brings accuracy to precision medicine
Biotech companies are leveraging the wealth of omics and imaging data to study deep phenotypes for a range of clinical applications including precision medicine approaches to liver disease, neurodegenerative disorders and infertility. With dozens of omics and imaging technologies in its arsenal, the biopharma industry is generating unprecedented amounts of data compared to just a […]